PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33139730-1	2020	Cyclin D1 is one of the most important oncoproteins that drives cancer cell proliferation and associates with tamoxifen resistance in breast cancer.	Tamoxifen	110-119	cyclin D1	Homo sapiens	0-9	
33139730-2	2020	Here, we identify a lncRNA, DILA1, which interacts with Cyclin D1 and is overexpressed in tamoxifen-resistant breast cancer cells.	Tamoxifen	90-99	cyclin D1	Homo sapiens	56-65	
33139730-5	2020	High expression of DILA1 is associated with overexpressed Cyclin D1 protein and poor prognosis in breast cancer patients who received tamoxifen treatment.	Tamoxifen	134-143	cyclin D1	Homo sapiens	58-67	
33139730-6	2020	This study shows the previously unappreciated importance of post-translational dysregulation of Cyclin D1 contributing to tamoxifen resistance in breast cancer.	Tamoxifen	122-131	cyclin D1	Homo sapiens	96-105	
33139730-7	2020	Moreover, it reveals the novel mechanism of DILA1 in regulating Cyclin D1 protein stability and suggests DILA1 is a specific therapeutic target to downregulate Cyclin D1 protein and reverse tamoxifen resistance in treating breast cancer.	Tamoxifen	190-199	cyclin D1	Homo sapiens	64-73